213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015

Olivier Benveniste¹, Lisa G Rider²; ENMC Myositis Outcomes Study Group

Collaborators, Affiliations

Collaborators

ENMC Myositis Outcomes Study Group:
R Aggarwal³, Y Allenbach⁴, O Benveniste⁴, J L De Bleecker⁵, I de Groot⁶, H Devilliers⁷, D Hilton-Jones⁸, J-Y Hogrel⁴, I E Lundberg⁹, A L Mammen¹⁰, Oakley¹¹, C Oddis³, G Padberg¹², D Ponce¹³, L G Rider¹⁰, M R Rose¹⁴, H Sanner¹⁵, A Selva-O'Callaghan¹⁶, M de Visser¹⁷, A Wells¹⁴, V P Werth¹⁸

Affiliations

¹ Département de Médecine Interne et Immunologie Clinique, Hôpital Pitié-Salpêtrière, DHU I2B, AP-HP, Paris, France; INSERM U974, UPMC Sorbonne Universités, Paris, France. Electronic address: olivier.benveniste@aphp.fr.
² Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA. Electronic address: riderl@mail.nih.gov.
³ Pittsburgh, PA, USA.
⁴ Paris, France.
⁵ Ghent, Belgium.
⁶ Member of the Myositis Workgroup of Spierziekten Nederland, The Netherlands.
⁷ Dijon, France.
⁸ Oxford, UK.
⁹ Stockholm, Sweden.
¹⁰ Bethesda, MD, USA.
¹¹ Myositis Support Group Southampton, UK.
¹² Research Director ENMC.
¹³ Manager of Group of Interest Inflammatory Myositis & Myositis Patient, AFM TELETHON, France.
¹⁴ London, UK.
¹⁵ Oslo, Norway.
¹⁶ Barcelona, Spain.
¹⁷ Amsterdam, The Netherlands.
¹⁸ Philadelphia, PA, USA.

PMID: 27312023
PMCID: PMC5118225
DOI: 10.1016/j.nmd.2016.05.014

213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015

Olivier Benveniste et al. Neuromuscul Disord. 2016 Aug.

. 2016 Aug;26(8):523-34.

doi: 10.1016/j.nmd.2016.05.014. Epub 2016 May 27.

Authors

Olivier Benveniste¹, Lisa G Rider²; ENMC Myositis Outcomes Study Group

Collaborators

ENMC Myositis Outcomes Study Group:
R Aggarwal³, Y Allenbach⁴, O Benveniste⁴, J L De Bleecker⁵, I de Groot⁶, H Devilliers⁷, D Hilton-Jones⁸, J-Y Hogrel⁴, I E Lundberg⁹, A L Mammen¹⁰, Oakley¹¹, C Oddis³, G Padberg¹², D Ponce¹³, L G Rider¹⁰, M R Rose¹⁴, H Sanner¹⁵, A Selva-O'Callaghan¹⁶, M de Visser¹⁷, A Wells¹⁴, V P Werth¹⁸

Affiliations

¹ Département de Médecine Interne et Immunologie Clinique, Hôpital Pitié-Salpêtrière, DHU I2B, AP-HP, Paris, France; INSERM U974, UPMC Sorbonne Universités, Paris, France. Electronic address: olivier.benveniste@aphp.fr.
² Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA. Electronic address: riderl@mail.nih.gov.
³ Pittsburgh, PA, USA.
⁴ Paris, France.
⁵ Ghent, Belgium.
⁶ Member of the Myositis Workgroup of Spierziekten Nederland, The Netherlands.
⁷ Dijon, France.
⁸ Oxford, UK.
⁹ Stockholm, Sweden.
¹⁰ Bethesda, MD, USA.
¹¹ Myositis Support Group Southampton, UK.
¹² Research Director ENMC.
¹³ Manager of Group of Interest Inflammatory Myositis & Myositis Patient, AFM TELETHON, France.
¹⁴ London, UK.
¹⁵ Oslo, Norway.
¹⁶ Barcelona, Spain.
¹⁷ Amsterdam, The Netherlands.
¹⁸ Philadelphia, PA, USA.

PMID: 27312023
PMCID: PMC5118225
DOI: 10.1016/j.nmd.2016.05.014

No abstract available

PubMed Disclaimer

References

1. Allenbach Y, Keraen J, Bouvier A-M, et al. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. Brain. 2016 doi:10.1093/brain/aww054. - PubMed
1. Hoogendijk JE, Amato AA, Lecky BR, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004;14:337–45. - PubMed
1. Amato AA, Griggs RC. Unicorns, dragons, polymyositis, and other mythological beasts. Neurology. 2003;61:288–9. - PubMed
1. Van der Meulen MF, Bronner IM, Hoogendijk JE, et al. Polymyositis: an overdiagnosed entity. Neurology. 2003;61:316–21. - PubMed
1. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senecal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Med Baltim. 2005;84:231–49. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

ZIA ES101081/ImNIH/Intramural NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015

Collaborators

Affiliations

213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015

Authors

Collaborators

Affiliations

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical